CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children

Clinical trial NCT04510051 · RECRUITING

Trial details

NCT number: NCT04510051
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Brain Neoplasm Recurrent Malignant Brain Neoplasm Refractory Malignant Brain Neoplasm

Start date: 2020-12-04
Primary completion: 2027-02-24
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.